Twenty-five recurrent BRCA1/2 mutations (including 18 mutations previously reported in Pakistani breast/ovarian cancer patients) have also been described elsewhere in the world, indicating that majority of mutations found in the current study did not differ from those previously reported in Pakistan or elsewhere. The gene discussed is BRCA1; the disease is ovarian carcinoma.